Kunshi Biotechnology: Funding, Investors & Team (Sep 2026)
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
Kunshi Biotechnology has raised $7.0M across 1 funding round on record, the most recent a Series A of $7.0M announced in Nov 2025.
That round is below the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kunshi Biotechnology Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Kunshi Biotechnology Funding Rounds
Kunshi Biotechnology Founders and Leadership Team
Contact details for the Kunshi Biotechnology team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Kunshi Biotechnology Funding Compared to Other Biotechnology Startups
Kunshi Biotechnology's latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kunshi Biotechnology in Biotechnology and Suzhou
Companies Similar to Kunshi Biotechnology
Weike Bio is a gene therapy drug development company.
Full-Life Technologies is a medical company providing development, production, and commercialization of…
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Twinpig Biolab researches and develops anticancer drugs.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Kunshi Biotechnology Funding FAQs
What does Kunshi Biotechnology do?
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
How much funding has Kunshi Biotechnology raised?
Kunshi Biotechnology has raised $7.0M across 1 round on record. The most recent is a Series A of $7.0M announced in Nov 2025.
When did Kunshi Biotechnology last raise funding?
Kunshi Biotechnology's most recent funding round on record is a Series A of $7.0M, announced in Nov 2025.
Where is Kunshi Biotechnology headquartered?
Kunshi Biotechnology is based in Suzhou, China.
How many employees does Kunshi Biotechnology have?
Kunshi Biotechnology is in the 51-100 employee band.
How does Kunshi Biotechnology's funding compare to other Biotechnology startups?
Kunshi Biotechnology's latest round of $7.0M is below the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's Kunshi Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kunshi Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.